Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cardiology

• Publication date

  2014-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2014.01.053PMID 24495652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.

  2010cited by this paper
• Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?

  2009cited by this paper
• Translational therapeutics of dipyridamole.

  2008cited by this paper
• Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat

  2008cited by this paper
• Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?

  2007cited by this paper
• Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.

  2007cited by this paper
• A Comparative Randomized and Placebo-controlled Short-term Trial of Aspirin and Dipyridamole for Overt Type-2 Diabetic Nephropathy

  2002cited by this paper

• Callistemon viminalis extracts: dual action on anxiety and neuroprotection via neuroinflammatory and serotonergic pathways

  2025cites this paper
• Exploring the therapeutic potential of Aloin: unraveling neuroprotective and anticancer mechanisms, and strategies for enhanced stability and delivery

  2024cites this paper
• Validating the Temporal Performance of Genetic Biomarkers in an Animal Model of Recurrence/ Non-recurrence Myocardial Infarction Persuades by Bioinformatic Tools.

  2024cites this paper
• con-SNAP@CQD as a promising therapeutic vehicle against HCoVs: An overview

  2023cites this paper
• The Role of Platelets in Diabetic Kidney Disease

  2022cites this paper
• Preliminary investigation on impact of intergenerational treatment of resveratrol endorses the development of 'super-pups'.

  2022cites this paper
• Dipyridamole for tracking amyloidogenic proteins aggregation and enhancing polyubiquitination.

  2022cites this paper
• Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor

  2022cites this paper
• Effect of pantoprazole on I-R-induced myocardial injury in diabetic rats targeting inflammatory cytokine release and oxidative stress

  2021cites this paper
• Dose and time-dependent toxicological impact of pantoprazole on vascular endothelium and renal tissue.

  2020cites this paper
• Pantoprazole Rescue The Vascular Endothelial Dysfunction In Diabetic Rats Through DDAH/ADMA/Enos/NO Pathway

  2020influential citation
• Evaluation of a hybrid small caliber vascular graft in a rabbit model.

  2020cites this paper
• Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology

  2020cites this paper
• Good Governance among Malaysian Government-Linked Companies: Detecting Earnings Manipulation through Beniesh M-Score and Ratio Analyses

  2019cites this paper
• Development and characterization of late‐stage diabetes mellitus and ‐associated vascular complications

  2019cites this paper
• Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction.

  2018cites this paper
• Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction

  2018cites this paper
• An Effective Risk Factor Detection and Disease Prediction (RFD-DP) Model Applied to Hypertension

  2018cites this paper
• Effect of ethanolic extract of Euphorbia hirta on chronic diabetes mellitus and associated cardiorenal damage in rats

  2018influential citation
• Glucagon Like Peptide (Glp – 1) Receptor: A Promising Therapeutic Target for Screening of Herbal Antidiabetic Compounds

  2018cites this paper
• Combined and individual strategy of exercise generated preconditioning and low dose copper nanoparticles serve as superlative approach to ameliorate ISO-induced myocardial infarction in rats

  2018cites this paper
• Preparation and therapeutic evolution of Ficus benjamina solid lipid nanoparticles against alcohol abuse/antabuse induced hepatotoxicity and cardio-renal injury

  2017cites this paper
• Effects of pre and post‐treatments with dipyridamole in gentamicin‐induced acute nephrotoxicity in the rat

  2017cites this paper
• Drug Repurposing Patent Applications January–March 2017

  2017cites this paper
• Progress and perspectives in bioactive agent delivery via electrospun vascular grafts

  2017cites this paper
• [Antithrombotic treatment as primary and secondary prevention of stroke].

  2016cites this paper
• Synthesis and preliminary therapeutic evaluation of copper nanoparticles against diabetes mellitus and -induced micro- (renal) and macro-vascular (vascular endothelial and cardiovascular) abnormalities in rats

  2016cites this paper
• Albiglutide: Is a better hope against diabetes mellitus?

  2016cites this paper
• Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.

  2015cites this paper
• Reactive oxygen species: friend or foe?

  2015cites this paper
• Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?

  2014cites this paper
• Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.

  2014cites this paper